These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 11166669
1. A possible interaction between CCKergic and GABAergic systems in the rat brain. Acosta GB. Comp Biochem Physiol C Toxicol Pharmacol; 2001 Jan; 128(1):11-7. PubMed ID: 11166669 [Abstract] [Full Text] [Related]
2. Administration of cholecystokinin sulphated octapeptide (CCK-8S) induces changes on rat amino acid tissue levels and on a behavioral test for anxiety. Acosta GB. Gen Pharmacol; 1998 Oct; 31(4):637-41. PubMed ID: 9792229 [Abstract] [Full Text] [Related]
3. Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes. You ZB, Godukhin O, Goiny M, Nylander I, Ungerstedt U, Terenius L, Hökfelt T, Herrera-Marschitz M. Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):576-81. PubMed ID: 9151295 [Abstract] [Full Text] [Related]
12. Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze. Zanoveli JM, Netto CF, Guimarães FS, Zangrossi H. Peptides; 2004 Nov; 25(11):1935-41. PubMed ID: 15501525 [Abstract] [Full Text] [Related]
13. Cholecystokinin-8 increases K(+)-evoked [3H] gamma-aminobutyric acid release in slices from various brain areas. Pérez de la Mora M, Hernandez-Gómez AM, Méndez-Franco J, Fuxe K. Eur J Pharmacol; 1993 Dec 21; 250(3):423-30. PubMed ID: 8112402 [Abstract] [Full Text] [Related]
14. Evidence for a nucleus accumbens CCK2 receptor regulation of rat ventral pallidal GABA levels: a dual probe microdialysis study. Ferraro L, O'Connor WT, Glennon J, Tomasini MC, Bebe BW, Tanganelli S, Antonelli T. Life Sci; 2000 Dec 22; 68(5):483-96. PubMed ID: 11197746 [Abstract] [Full Text] [Related]
15. Intraperitoneal, but not subcutaneous, administration of the sulphated cholecystokinin octapeptide (CCK-8S) inhibits operant and nonoperant food intake in rats: implications for the CCK-satiety hypothesis. Ebenezer IS. Methods Find Exp Clin Pharmacol; 1999 Apr 22; 21(3):167-71. PubMed ID: 10389118 [Abstract] [Full Text] [Related]
16. Central administration of cholecystokinin stimulates gastric pepsinogen secretion from anaesthetized rats. Blandizzi C, Natale G, Carignani D, Colucci R, Lazzeri G, Del Tacca M. Neurosci Lett; 1995 Jun 23; 193(1):13-6. PubMed ID: 7566655 [Abstract] [Full Text] [Related]
17. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat. Gronier B, Debonnel G. Synapse; 1995 Oct 23; 21(2):158-68. PubMed ID: 8584977 [Abstract] [Full Text] [Related]
18. Effects of cholecystokinin peptides and GV 150013, a selective cholecystokininB receptor antagonist, on electrically evoked endogenous GABA release from rat cortical slices. Ferraro L, Beani L, Trist D, Reggiani A, Bianchi C. J Neurochem; 1999 Nov 23; 73(5):1973-81. PubMed ID: 10537055 [Abstract] [Full Text] [Related]
19. Cholecystokinin-8 regulation of NGF concentrations in adult mouse brain through a mechanism involving CCK(A) and CCK(B) receptors. Tirassa P, Stenfors C, Lundeberg T, Aloe L. Br J Pharmacol; 1998 Mar 23; 123(6):1230-6. PubMed ID: 9559909 [Abstract] [Full Text] [Related]
20. The trophic response of rat pancreas to sulfated cholecystokinin-8 is dose- and time-dependent and not affected by vagotomy or atropine. Nylander AG, Chen D, Ding XQ, Norlén P, Håkanson R. Pharmacol Toxicol; 1997 Mar 23; 80(3):142-6. PubMed ID: 9101587 [Abstract] [Full Text] [Related] Page: [Next] [New Search]